While innovation lays the bedrock for differentiation and business success, the area of innovation is relatively lesser served by technology and decision support solutions. We recognize this critical gap. Our innovation intelligence products address the shortcomings in the different stages of the innovation lifecycle and make it more efficient and informed. We do this by leveraging the power of Deep Learning, AI / ML and our unique techniques. Minimize Risks to Innovation through Proactive, Collective and Informed Decisions
AIRA (Automated Intelligent Research Assistant) aims to mitigate the risks to the business & innovation strategy of organizations by facilitating proactive decisions powered by AI enabled insights.
This enables companies to be better prepared to tackle the uncertainties of the dynamic global market.
AIRA's unique sourcing engine captures the most relevant business and technology information that are relevant to your area of interest, continuously from world-wide information sources.
AIRA's Area of Interest Model and Relevance Ranking Engine enables efficient discovery of relevant content
Inventive patent pending techniques to enable the users to define their analysis scope or areas of interest in a unique and comprehensive way
Extended coverage of analysis that goes beyond patents to include multiple content types from various sources to extract Technology and Business Insights
Capability to sift through thousands of documents for relevance, leveraging multiple AI enabled levers for efficient discovery
Unique "On the Fly Database" approach of sourcing data just prior to analysis and thus serve as a "Competitor Radar" watching out for events of interest
CURATUS brings together multiple stakeholders involved in competitor decisions including Attorneys, Analysts, Technologists etc. and enables actionable insights by facilitating seamless collaborative review of curated Patents and Non-Patent Literature.
CURATUS is source agonistic and can be used with patent databases of your choice.
Review Center & Email alerts adds efficiency to the overall collaboration process.
Role-based access, private reviews and secure sand-boxes balance between org level visibility & departmental privacy.
Upload curated patents and keep them refreshed from patent aggregators such as Espacenet.
Upload curated patents and keep them refreshed from patent aggregators such as Espacenet.
Better management and control of the workflows with differentiated user access (e.g. IP Analysts vs. Attorneys & Technologists)
Attend to the relevant curated data coming into the system, which are in the areas of interest
Augment the Technology & Competitor Insights from Patents, with curated News feeds and updates
Through AIRA Med, we offer a Platform + Services model, to deliver In Silico Services, leveraging the power of AI and Analytics.
This address a variety of drug research problems including,
AIRA Med offerings focus on delivering transparent and explainable AI outcomes
Capability to source and manage bio med data from multiple sources
Bag of Algorithms for Parameter Prediction, Toxicity Profiling and Systemic Availability Profiling of Small Molecules
BioMed Knowledge Graph that is built iteratively as we solve more problems
Leverage the power of AI to take timely decisions and effective interventions to improve your competitive advantage.
Combine the power of our innovations and the advancements in the Big Data Technology, Analytics, Machine Learning & AI to manage, massive and complex data efficiently and extract valuable insights from the same.
We will work with you through the entire lifecycle of your custom AI solution, right from problem definition to solution conceptualization to prototyping to development and successful delivery. Irrespective of the type of end deliverable, be it a report of curated insights or a self service decision support solution or a platform that guides you with the right recommendations, we can be your partner of choice for your AI adoption journey.
Our AI Solutions solutions span multiple business domains and add value to their primary areas of concern.
OOS Analysis Solution is a critical enabler for any quality centric organization that aims at improving the efficacy of their quality processes and their credibility. It leverages AI's capability to perform deep analysis of textual information to extract actionable insights from the same.
AI powered Out of Specification (OOS) Analysis Solution enables deep analysis of OOS data, extraction of Root Causes from them and their classifications by areas of accountabilities.
The Solution directly contributes towards, improvement of Quality Data, Targeted Interventions for Quality Improvement which leads to reduction of Invalidated OOS
Case StudyBusinesses around the globe are adopting Digital as their primary channel of operation / customer interaction, and this exposes them to newer opportunities and challenges. This calls for advanced capabilities like digital behaviour analysis of the online clients, for better risk management.
Digital Behaviour Analysis offers a framework to non intrusively and seamlessly collect, store and process the interaction events of the user. This trail of interaction patterns can be used to predict user intention and motivation.
This solution thus opens up a new opportunity to predict the user intention and manage the risks, if any, in a non intrusive manner.
Quality centric organizations - like pharma companies, look out for opportunities to reduce the Deviations by targeted Corrective and Preventive Actions. Even with this Deviations do recur. While recurrence of Deviations highlights ineffective CAPA, information about the past similar Deviations gives an opportunity to address the recent Deviation in an informed way.
AI based Deviations Similarity Search solution performs a similarity analysis of the Deviation records, which gives an accurate view into the recurrence of Deviations.
This will enable better CAPA effectiveness and thereby improved quality processes and end product quality.
Pharma majors are actively exploring opportunities to drive efficient and cost effective innovation. With loads of valuable and relevant drug related information available publicly, AI driven models can be leveraged for this.
Our In Silico Analysis offerings aims at finding answers to complex Bio Med questions related to drug research, in an effective way. We leverage the capabilities of our AIRA Med Platform towards this.
This facilitates ADMET screening for molecules, Development of a Repurposing Strategy & Portfolio, Target ranking for a Disease, Route Scouting and Predictions of specific properties and capabilities of molecules.
With a global trend that is pushing consumers away from fossil fuels, auto companies and their ancillaries are moving towards electromobility. This space is seeing some tectonic shifts, with new technology adoptions and dynamic business relationships and the stakeholders need to be up to date on these developments.
The EV Competitor Watch offering leveraged AIRA and its unique Insight Explorer to mine out the emerging business and technology events in the electromobility space.
The insights offered regarding the recent developments in the EV space can help the Auto and their ancillary businesses to manage their investments well.
Material Science research involves a series of research activities performed by R&D teams manually to observe and measure the properties of the individual molecules and their combinations
Material Property Solution aims at leveraging advanced analytics and AI Models to extract and predict the properties of the molecules and combinations from information available in the inhouse research data as well as public information.
This will help the R&D teams to identify better molecules and combinations and thus accelerate their R&D activities
We are an AI Product & Solutions company founded with the vision of revolutionizing how companies innovate and how efficiently these innovations can be taken to the market.
While our AI centric product AIRA helps our innovative clients improve the efficiency of their research, our AI solutions help our clients to adopt AI effectively into their operational fabric to automate activities requiring human intelligence and reasoning.
We are committed to building a winning organization and strongly believe the course of success can only be charted by a peerless workforce. As a team we exhibit and value a culture of leadership, collaboration and performance.
Ownership and a fearless getting things done attitude
Teamwork, openness and complementing each other's strengths
High personal standards, peer recognition and mentoring
Global Pharma Company brings down their Rate of Invalidated OOS
A global pharmaceutical company with a major focus in the development and manufacture of IP-led niche finished dosage formulations.
As part of its quality improvement strategy, the company was interested in bringing down the Rate of IOOS (Invalidated Out of Specification).
BigInfo Labs implemented the AI enabled OOS Analysis Solution with real time integration with the companies Quality OOS Management / OOS Tracking System
This was delivered as a hosted solution with API enabled integration.
BigInfo Labs OOS Analysis Solution's automated Root Cause Extraction & Classification engine performed real time analysis of the OOS Records and alerted the Analysts over email.
VALUE DELIVERED Value to the Analysts Analysts used the real time validation capability of the solution to review the of "Clarity" of their Comments and "Accuracy" of their Classifications This served as a real enabler for the Analysts and facilitated the onboarding of new Analysts Value to OOS Data Quality The real time validation of Analyst's comments and template validations ensured "Clarity, Accuracy & Completeness" of the Comments This ensured better OOS data quality Value to Quality Improvement Analyst enablement and improved OOS Data quality have supported and contributed to the overall quality initiatives at the pharma company The company observed a drastic reduction in the IOOS (42% reduction)